PRILOSEC

This brand name is authorized in United States

Active ingredients

The drug PRILOSEC contains one active pharmaceutical ingredient (API):

1 Omeprazole UNII 426QFE7XLK - OMEPRAZOLE MAGNESIUM

Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing. Read about Omeprazole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PRILOSEC Granule for delayed-release oral suspension	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A02BC01	Omeprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 70515-610, 70515-625, 80425-0070, 80425-0071